-
-
-
-
-
-
-
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
-
-
-
-
-
-
-
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
-
-
-
-
-
-
-
Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq
-
-
-
-
-
-
-
Innate Pharma Reports First Half 2022 Financial Results and Business Update
-
-
-
-
-
-
-
Innate Pharma Reports First Half 2021 Financial Results and Business Update
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Reata Pharmaceuticals, Evolus, Las Vegas Sands, and Innate Pharma and Encourages Investors to Contact t
-
-
-
-
-
-
-
Innate Pharma Reports Full Year 2019 Financial Results and Business Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

